Crossmark

Efficacy and safety of PARPis combined with an ICIs for advanced or metastatic triple-negative breast cancer: a single-arm meta-analysis

Published Online: 2024-09-04

Published Print: 2024-12

Authors

Zheng, Qiao

Zhou, Tiecheng

Ding, Weijun
License Information

Text and Data Mining valid from 2024-09-04

Version of Record valid from 2024-09-04
More Information

Article History

Received: 23 April 2024

Accepted: 17 August 2024

First Online: 4 September 2024

Declarations

:

: The authors declare no competing interests.

Document is current